At the time of writing, Agilon Health Inc [AGL] stock is trading at $1.09, up 2.83%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AGL shares have gain 9.00% over the last week, with a monthly amount drifted -5.22%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Agilon Health Inc [NYSE: AGL] stock has seen the most recent analyst activity on August 20, 2025, when Bernstein downgraded its rating to a Mkt Perform but kept the price target unchanged to $1.40 for it. Previously, Citigroup downgraded its rating to Neutral on August 06, 2025, and kept the price target unchanged to $1. On April 25, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $5 on the stock. Bernstein upgraded its rating to a Outperform but stick to its price target of $8.50 on April 08, 2025. Citigroup upgraded its rating to a Neutral and raised its price target to $2.25 on January 10, 2025. In a note dated December 16, 2024, Macquarie initiated an Neutral rating.
For the past year, the stock price of Agilon Health Inc fluctuated between $0.71 and $6.08. Currently, Wall Street analysts expect the stock to reach $1.3 within the next 12 months. Agilon Health Inc [NYSE: AGL] shares were valued at $1.09 at the most recent close of the market. An investor can expect a potential return of 19.27% based on the average AGL price forecast.
Analyzing the AGL fundamentals
According to Agilon Health Inc [NYSE:AGL], the company’s sales were 5.90B for trailing twelve months, which represents an -5.92% plunge. Gross Profit Margin for this corporation currently stands at -0.02% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.18, Equity is -0.65 and Total Capital is -0.82. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0433 points at the first support level, and at 0.9967 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1133, and for the 2nd resistance point, it is at 1.1367.
Ratios To Look Out For
It is important to note that Agilon Health Inc [NYSE:AGL] has a current ratio of 1.16. As well, the Quick Ratio is 1.16, while the Cash Ratio is 0.14. Considering the valuation of this stock, the price to sales ratio is 0.08, the price to book ratio is 1.10.
Transactions by insiders
Recent insider trading involved McLoughlin Karen, Director, that happened on Dec 13 ’24 when 25000.0 shares were purchased. Director, Battaglia Silvana completed a deal on Dec 11 ’24 to buy 25062.0 shares. Meanwhile, Director MCKENZIE DIANA bought 12500.0 shares on Nov 25 ’24.
